These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 20167939)

  • 21. Lipopolysaccharide-induced myocardial protection against ischaemia/reperfusion injury is mediated through a PI3K/Akt-dependent mechanism.
    Ha T; Hua F; Liu X; Ma J; McMullen JR; Shioi T; Izumo S; Kelley J; Gao X; Browder W; Williams DL; Kao RL; Li C
    Cardiovasc Res; 2008 Jun; 78(3):546-53. PubMed ID: 18267957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endothelial nitric oxide synthase plays an obligatory role in the late phase of ischemic preconditioning by activating the protein kinase C epsilon p44/42 mitogen-activated protein kinase pSer-signal transducers and activators of transcription1/3 pathway.
    Xuan YT; Guo Y; Zhu Y; Wang OL; Rokosh G; Bolli R
    Circulation; 2007 Jul; 116(5):535-44. PubMed ID: 17606840
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
    Mozaffari MS; Schaffer SW
    Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
    Palfi A; Toth A; Hanto K; Deres P; Szabados E; Szereday Z; Kulcsar G; Kalai T; Hideg K; Gallyas F; Sumegi B; Toth K; Halmosi R
    J Mol Cell Cardiol; 2006 Jul; 41(1):149-59. PubMed ID: 16716347
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ischemic postconditioning attenuates ischemia/reperfusion injury in isolated hypertrophied rat heart].
    Peng LY; Ma H; He JG; Gao XR; Zhang Y; He XH; Zhai YS; Zhang XJ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Aug; 34(8):685-9. PubMed ID: 17081389
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Opioid-induced cardioprotection occurs via glycogen synthase kinase beta inhibition during reperfusion in intact rat hearts.
    Gross ER; Hsu AK; Gross GJ
    Circ Res; 2004 Apr; 94(7):960-6. PubMed ID: 14976126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. No risk, no ... cardioprotection? A critical perspective.
    Heusch G
    Cardiovasc Res; 2009 Nov; 84(2):173-5. PubMed ID: 19713282
    [No Abstract]   [Full Text] [Related]  

  • 28. Age-associated differences in activation of Akt/GSK-3beta signaling pathways and inhibition of mitochondrial permeability transition pore opening in the rat heart.
    Zhu J; Rebecchi MJ; Tan M; Glass PS; Brink PR; Liu L
    J Gerontol A Biol Sci Med Sci; 2010 Jun; 65(6):611-9. PubMed ID: 20427381
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Glycogen synthase kinase 3 inhibition protects the heart from acute ischemia-reperfusion injury via inhibition of inflammation and apoptosis.
    Gao HK; Yin Z; Zhou N; Feng XY; Gao F; Wang HC
    J Cardiovasc Pharmacol; 2008 Sep; 52(3):286-92. PubMed ID: 18806610
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardioprotection by postconditioning is lost in WOKW rats with metabolic syndrome: role of glycogen synthase kinase 3beta.
    Wagner C; Kloeting I; Strasser RH; Weinbrenner C
    J Cardiovasc Pharmacol; 2008 Nov; 52(5):430-7. PubMed ID: 19033822
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reoxygenation after severe hypoxia induces cardiomyocyte hypertrophy in vitro: activation of CREB downstream of GSK3beta.
    El Jamali A; Freund C; Rechner C; Scheidereit C; Dietz R; Bergmann MW
    FASEB J; 2004 Jul; 18(10):1096-8. PubMed ID: 15155564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell therapy for heart disease: to genetically modify or not, that is the question.
    Mushtaq M; Oskouei BN; Hare JM
    Circ Res; 2011 Feb; 108(4):398-401. PubMed ID: 21335427
    [No Abstract]   [Full Text] [Related]  

  • 33. Circadian influence in cardiovascular disease (Part 2).
    Valle GA; Lemberg L
    Chest; 1990 Jul; 98(1):218-21. PubMed ID: 2193781
    [No Abstract]   [Full Text] [Related]  

  • 34. [Opinions on the effect of time of day on onset of myocardial infarction and safety of physical exertion].
    Markiewicz A; Osiadło G
    Pol Arch Med Wewn; 1996 Sep; 96(3):284-9. PubMed ID: 9122021
    [No Abstract]   [Full Text] [Related]  

  • 35. Circadian aspects of myocardial infarction among young STEMI patients.
    Fournier S; Muller O
    Eur J Intern Med; 2016 Jan; 27():e5-6. PubMed ID: 26297336
    [No Abstract]   [Full Text] [Related]  

  • 36. Myocardial repair around-the-clock.
    Sharma UC; Canty JM
    Circ Res; 2014 May; 114(11):1675-7. PubMed ID: 24855196
    [No Abstract]   [Full Text] [Related]  

  • 37. Clocks, Rhythms, Sex, and Hearts: How Disrupted Circadian Rhythms, Time-of-Day, and Sex Influence Cardiovascular Health.
    Meléndez-Fernández OH; Walton JC; DeVries AC; Nelson RJ
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34198706
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NK1-receptor-expressing paraventricular nucleus neurones modulate daily variation in heart rate and stress-induced changes in heart rate variability.
    Feetham CH; Barrett-Jolley R
    Physiol Rep; 2014 Dec; 2(12):. PubMed ID: 25472606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is there a better time of day to have a heart attack?
    Lefer DJ
    Circ Res; 2010 Feb; 106(3):430-1. PubMed ID: 20167939
    [No Abstract]   [Full Text] [Related]  

  • 40. Short communication: ischemia/reperfusion tolerance is time-of-day-dependent: mediation by the cardiomyocyte circadian clock.
    Durgan DJ; Pulinilkunnil T; Villegas-Montoya C; Garvey ME; Frangogiannis NG; Michael LH; Chow CW; Dyck JR; Young ME
    Circ Res; 2010 Feb; 106(3):546-50. PubMed ID: 20007913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.